» Articles » PMID: 15364667

Cost-related Medication Underuse: Do Patients with Chronic Illnesses Tell Their Doctors?

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2004 Sep 15
PMID 15364667
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although many chronically ill patients underuse prescription medications because of cost concerns, we know little about their discussions with clinicians about this issue.

Methods: Nationwide survey of 660 older adults with chronic illnesses who reported underusing medication in the prior year because of cost. We assessed whether patients discussed cost-related medication underuse with clinicians, reasons that some patients did not talk with clinicians about this problem, how clinicians responded when this issue was raised, and how helpful patients perceived clinicians to be.

Results: Two thirds of respondents never told a clinician in advance that they planned to underuse medication because of the cost, and 35% never discussed the issue at all. Of those who did not tell a clinician, 66% reported that nobody asked them about their ability to pay for prescriptions and 58% reported that they did not think providers could help them. When patients talked with clinicians about medication costs, 72% found those conversations helpful. However, 31% reported that their medications were never changed to a generic or less expensive alternative, and few patients were given other forms of assistance such as information about programs that help pay drug costs (30%) or where to purchase less expensive medication (28%). Patients were most likely to find clinicians helpful if clinicians provided free samples, asked about problems paying for prescriptions, and offered advice about how to pay for patients' current regimens.

Conclusions: About one third of chronically ill adults who underuse prescription medication because of the cost never talk with clinicians in advance, and many never raise this issue at all. Clinicians should take a more proactive role in identifying and assisting patients who have problems paying for prescription drugs.

Citing Articles

Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey.

Shen Q, Chua D, Chan P, Chan S, Wee H Patient Prefer Adherence. 2025; 19:407-418.

PMID: 40012849 PMC: 11863787. DOI: 10.2147/PPA.S502235.


Association between under-dose of enzyme replacement therapy and quality of life in adults with late-onset Pompe disease in China: A retrospective matched cohort study.

Zhang H, Chen S, Xu R, Yu S, Yu J, Dong D PLoS One. 2024; 19(9):e0310534.

PMID: 39288112 PMC: 11407662. DOI: 10.1371/journal.pone.0310534.


National survey of patient perspectives on cost discussions among recipients of copay assistance.

Lam A, Nipp R, Hasler J, Hu B, Zahner G, Robbins S Oncologist. 2024; 29(11):e1540-e1551.

PMID: 38864681 PMC: 11546722. DOI: 10.1093/oncolo/oyae148.


The potential impact of introducing a cost tool to facilitate cost-of-care conversations in routine OB care: Lessons from the CONTINUE pilot study.

Fitzpatrick V, Erwin K, Rivelli A, Shields M, Delfinado L, Cabiya M PEC Innov. 2023; 2:100136.

PMID: 37214536 PMC: 10194338. DOI: 10.1016/j.pecinn.2023.100136.


Cost awareness amongst irish ophthalmologists.

Power B Ir J Med Sci. 2023; 192(6):3147-3150.

PMID: 37119367 PMC: 10692008. DOI: 10.1007/s11845-023-03332-7.